Trial reportWorld journal of urology2026
Prevention of ureteral stone migration during percutaneous nephrolithotomy: a randomized controlled trial.
Trial report in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWith the increasing adoption of totally tubeless percutaneous nephrolithotomy (ttPCNL), prevention of stone fragment migration into the ureter has gained clinical importance. This study aimed to compare the incidence of ureteral fragment migration at the end of PCNL using a 5 Fr open-ended ureteral catheter (5FrUC) versus an occlusion balloon catheter (OBC).
methodsIn this IRB-approved randomized controlled trial, 108 eligible patients were randomized 1:1 to either the 5FrUC or OBC group and 99 were included in the final analysis. The primary outcome, ureteral fragment migration, was defined as the presence of any stone fragment ≥ 1 mm between the ureteropelvic junction (UPJ) and ureterovesical junction (UVJ), confirmed by ureteroscopy at the conclusion of PCNL.
resultsBaseline demographics, stone characteristics, and operative parameters were comparable between groups, confirming effective randomization. Ureteral fragments were detected in 10 patients (10%): 7 with a single fragment, 2 with two fragments, and 1 with more than three fragments. The median fragment size was 2 mm (range, 1-4 mm). The incidence of ureteral fragments was significantly higher in the 5FrUC group compared with the OBC group (17% vs. 4%, p = 0.03). Logistic regression analysis demonstrated that OBC use reduced the risk of ureteral fragment migration by approximately 80% compared with 5FrUC (OR = 0.204, 95%CI 0.041-1.001, p = 0.05). Greater total stone burden, larger stone volume, higher Guy's stone score, and presence of full staghorn calculi were also associated with fragment migration.
conclusionUse of an occlusion balloon catheter significantly reduced ureteral fragment migration compared with a 5 Fr open-ended ureteral catheter, achieving prevention in 96% of cases. Although the clinical impact of residual ureteral fragments remains uncertain, these findings support consideration of OBC use, particularly in ttPCNL procedures.
Indexed as
Identifiers
42543393What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.